Hepatitis A in the EU/EEA: The case for scaling up prevention

Vaccine. 2018 May 3;36(19):2501-2503. doi: 10.1016/j.vaccine.2018.02.100. Epub 2018 Apr 5.

Authors

Lara Tavoschi¹, Ettore Severi², Paloma Carrillo Santisteve³, Pierluigi Lopalco⁴

Affiliations

¹ Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy.
² Karolinska Institut, Stockholm, Sweden.
³ Office of Birth and Childhood, Brussels, Belgium.
⁴ Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy. Electronic address: pierluigi.lopalco@unipi.it.

PMID: 29628152
DOI: 10.1016/j.vaccine.2018.02.100

No abstract available

Keywords: Hepatitis A; hepatitis A vaccines; vaccination.

MeSH terms

Europe / epidemiology
European Union / statistics & numerical data
Hepatitis A / epidemiology
Hepatitis A / prevention & control*
Hepatitis A / transmission
Hepatitis A Vaccines / therapeutic use*
Humans
Mass Vaccination

Substances

Hepatitis A Vaccines